Trial intelligence / Profile preview

Dead Sea Peloid Gel for Chronic Endometritis

NCT02680275Completed

Start
Jul 2011
Primary completion
Jun 2013
Modality
Transdermal Patches, Nucleic Acid-Directed Small Molecules, Hydrogel Systems
Countries
1
01

Overview

Randomised, double-blind trial of dead sea peloid gel in endometritis. Primary endpoint: Prevalence of spontaneous pregnancy the first year after treatment at 1 year. Started Jul 2011; status: completed.

02

Drugs

dead sea peloid gel
03

Conditions

endometritis

Beyond the preview

Go deeper on NCT02680275.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02680275.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call